CAS: 146126-21-8; 9-(9-(6-Amino-9H-Purin-9-yl)-3,5,10,12-Tetrahydroxy-5,12-Dioxidooctahydro-2H,7H-Difuro[3,2-D:3',2'-J][1,3,7,9]Tetraoxa[2,8]Diphosphacyclododecin-2-yl)-1,9-Dihydro-6H-Purin-6-One--Triethylamine (1/2)

专利信息

专利号:US-9724673-B2
优先权日:2011-06-30
标 题:Supported alkoxylated organotin reactant, preparation and use for heterogeneous-phase synthesis of tetrazoles
发明人：LE GROGNEC ERWAN; QUINTARD JEAN-PAUL; KERRIC GAELLE; CHRETIEN JEAN-MATHIEU; ZAMMATTIO FRANCOISE
权利人:LE GROGNEC ERWAN; QUINTARD JEAN-PAUL; KERRIC GAELLE; CHRETIEN JEAN-MATHIEU; ZAMMATTIO FRANCOISE; UNIV NANTES; CENTRE NAT RECH SCIENT
摘要:A supported alkoxylated organotin reactant, to the process for preparing same, to the use of such a reactant as a catalyst for heterogeneous-phase organic synthesis, and also to a process for heterogeneous-phase synthesis of 5-substituted or 1,5-disubstituted tetrazoles using such a reactant.

专利号:US-7485672-B2
优先权日:2001-08-02
标 题:Process for the synthesis of soluble, high molecular weight polymers
发明人：MOLOCK FRANK; TURNER DAVID C; MAHADEVAN SHIVKUMAR; HEPTING JOSEPH
权利人:JOHNSON & JOHNSON VISION CARE
摘要:The present invention relates to a process comprising polymerizing via irradiation from a light source, a reaction mixture comprising at least one monomer and at least one photoinitiator wherein at least about 90% of incident light emitted by the light source is filtered to produce a soluble, high molecular weight polymer.

专利号:US-7216975-B2
优先权日:2003-07-15
标 题 :Method for preparing the reactive tinting compound and the tinted contact lens
发明人：HONG SHINN-GWO
权利人:HONG SHINN-GWO
摘要:A method for preparing the tinted contact lens with the covalently bonded novel reactive tinting compound is disclosed. The reactive tinting compound with mono vinyl functionality is prepared by reacting the reactive dye with a hydrophilic monomer containing both pendent hydroxyl and vinyl groups under an alkaline condition. The water soluble reactive dyes containing either difluoro-chloropyrimidine or β-sulphatoethylsulphone reactive groups are used for synthesis of the reactive tinting dye. The lens forming materials are photo-polymerized in the presence of the reactive tinting compound to prepare a tinted contact lens. The reactive tinting compound is copolymerized with the lens forming monomers in a single photo-polymerization step that requires no subsequently alkaline soaking or developing step as used in the prior art. In addition, the covalently bonded dye is stable and durable in the lens and does not fade or leach out after multiple high-pressure thermal sterilizations.

专利号:US-12356772-B2
优先权日:2020-07-08
标 题:Method of improving performance of devices with QDs comprising thin metal oxide coatings
发明人：KIM DAEKYOUNG; GUO WENZHOU; BARRERA DIEGO; MA RUIQING
权利人:SHOEI CHEMICAL IND CO
摘要:The invention is in the field of nanostructure synthesis. Provided are highly luminescent nanostructures, particularly highly luminescent quantum dots, comprising a nanocrystal core/shell and a thin metal oxide on the outer shell of the nanostructure. Also provided are methods of preparing the nanostructures, films comprising the nanostructures, and devices comprising the nanostructures.

专利号:US-2005054745-A1
优先权日:2001-08-02
标 题 :Process for the synthesis of soluble, high molecular weight polymers

专利号:US-11326164-B2
优先权日:2019-09-29
标 题:Trimethylglycylglycerin compositions and their use in developing anti-cancer drugs and RNA vaccines
发明人：LIN SHI-LUNG; CHANG-LIN SAMANTHA; CHANG CHIN-TSYH DONALD
权利人:WJWU & LYNN INSTITUTE FOR STEM CELL RES; MELLO BIOTECH TAIWAN CO LTD
摘要:This invention generally relates to a group of novel chemical compositions and their use for formulating RNA- and/or DNA-based medicine drugs/vaccines into stable compound complexes useful for both in-vitro and in-vivo delivery. Particularly, the present invention teaches the synthesis of a group of novel trimethylglycyl chemicals and their use for formulating cosmetic, therapeutic- and/or pharmaceutical-grade nucleic acid compositions, including but not limited microRNA precursors (pre-miRNA/miRNA), small hairpin RNAs (shRNA), short interfering RNAs (siRNA), ribozymes, antisense oligonucleotides, RNA-DNA hybrids and DNA-based vectors/vaccines, with or without modification, into delivery complexes, which can then be absorbed by cells in vivo, ex vivo and/or in vitro through an active mechanism of endocytosis via acetylcoline receptors for releasing the therapeutic and pharmaceutical effects of the formulated nucleic acid compositions.